首页> 外文期刊>Journal of immunology research. >HLA-A2-Restricted Epitopes Identified from MTA1 Could Elicit Antigen-Specific Cytotoxic T Lymphocyte Response
【24h】

HLA-A2-Restricted Epitopes Identified from MTA1 Could Elicit Antigen-Specific Cytotoxic T Lymphocyte Response

机译:从MTA1确定的HLA-A2限制性抗原决定簇可以引发抗原特异性的细胞毒性T淋巴细胞反应

获取原文
           

摘要

Overexpression of metastasis-associated protein 1 (MTA1) has been observed in many human malignancies and is significantly related to tumor invasion and metastasis, therapeutic resistance to radiation and chemotherapy, making MTA1 an ideal candidate tumor antigen. We identified several human leukocyte antigen- (HLA-) A2-restricted epitopes in MTA1 and evaluated their binding ability to HLA-A0201 molecules. Subsequently, a recombinant fragment encompassing the dominant epitopes, MTA1(1–283), was expressed, and the abilities of the selected epitopes of MTA1 and the MTA1(1–283) fragment to induce cytotoxic T lymphocytes (CTLs) were examined. Our results indicated that the epitopes and MTA1(1–283) fragment elicited HLA-A2-restricted and antigen-specific CTL responses both in vitro and in vivo. The new epitopes identified here may help promote the development of new therapeutic vaccines for HLA-A2
机译:已在许多人类恶性肿瘤中发现了与转移相关的蛋白1(MTA1)的过表达,它与肿瘤的侵袭和转移,对放射线和化学疗法的治疗抗性密切相关,从而使MTA1成为理想的候选肿瘤抗原。我们在MTA1中鉴定了几种人类白细胞抗原-(HLA-)A2限制性表位,并评估了它们与HLA-A0201分子的结合能力。随后,表达了一个包含主要表位MTA1(1-283)的重组片段,并检测了所选MTA1和MTA1(1-283)片段的表位诱导细胞毒性T淋巴细胞(CTL)的能力。我们的结果表明,抗原决定簇和MTA1(1-283)片段在体内外均引起HLA-A2限制性和抗原特异性CTL反应。此处鉴定的新表位可能有助于促进HLA-A2新型治疗疫苗的开发

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号